BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1731784)

  • 1. Therapy with coenzyme Q10 of patients in heart failure who are eligible or ineligible for a transplant.
    Folkers K; Langsjoen P; Langsjoen PH
    Biochem Biophys Res Commun; 1992 Jan; 182(1):247-53. PubMed ID: 1731784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective and safe therapy with coenzyme Q10 for cardiomyopathy.
    Langsjoen PH; Folkers K; Lyson K; Muratsu K; Lyson T; Langsjoen P
    Klin Wochenschr; 1988 Jul; 66(13):583-90. PubMed ID: 3062263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q10.
    Langsjoen PH; Vadhanavikit S; Folkers K
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4240-4. PubMed ID: 3858877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10.
    Folkers K; Vadhanavikit S; Mortensen SA
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):901-4. PubMed ID: 3856239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coenzyme Q10 in dilated cardiomyopathy.
    Manzoli U; Rossi E; Littarru GP; Frustaci A; Lippa S; Oradei A; Aureli V
    Int J Tissue React; 1990; 12(3):173-8. PubMed ID: 2276896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study.
    Berman M; Erman A; Ben-Gal T; Dvir D; Georghiou GP; Stamler A; Vered Y; Vidne BA; Aravot D
    Clin Cardiol; 2004 May; 27(5):295-9. PubMed ID: 15188947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pronounced increase of survival of patients with cardiomyopathy when treated with coenzyme Q10 and conventional therapy.
    Langsjoen PH; Folkers K; Lyson K; Muratsu K; Lyson T; Langsjoen P
    Int J Tissue React; 1990; 12(3):163-8. PubMed ID: 2276894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective treatment with coenzyme Q10 of patients with chronic myocardial disease.
    Langsjoen PH; Vadhanavikit S; Folkers K
    Drugs Exp Clin Res; 1985; 11(8):577-9. PubMed ID: 3836875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of coenzyme Q10 on idiopathic chronic dilated cardiomyopathy in children.
    Soongswang J; Sangtawesin C; Durongpisitkul K; Laohaprasitiporn D; Nana A; Punlee K; Kangkagate C
    Pediatr Cardiol; 2005; 26(4):361-6. PubMed ID: 16374685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of coenzyme Q10 in clinical cardiology: a long-term study.
    Langsjoen H; Langsjoen P; Langsjoen P; Willis R; Folkers K
    Mol Aspects Med; 1994; 15 Suppl():s165-75. PubMed ID: 7752828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of ubiquinone (coenzyme Q10) in pediatric cardiomyopathy.
    Bhagavan HN; Chopra RK
    Clin Nutr; 2005 Jun; 24(3):331-8. PubMed ID: 15896419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview on coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end-points of "Q-symbio"--a multinational trial.
    Mortensen SA
    Biofactors; 2003; 18(1-4):79-89. PubMed ID: 14695923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Coenzyme Q10: contractile dysfunction of the myocardial cell and metabolic therapy].
    Davini A; Cellerini F; Topi PL
    Minerva Cardioangiol; 1992 Nov; 40(11):449-53. PubMed ID: 1291925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coenzyme Q10: clinical benefits with biochemical correlates suggesting a scientific breakthrough in the management of chronic heart failure.
    Mortensen SA; Vadhanavikit S; Muratsu K; Folkers K
    Int J Tissue React; 1990; 12(3):155-62. PubMed ID: 2276893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term coenzyme Q10 therapy: a major advance in the management of resistant myocardial failure.
    Mortensen SA; Vadhanavikit S; Baandrup U; Folkers K
    Drugs Exp Clin Res; 1985; 11(8):581-93. PubMed ID: 3836876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coenzyme Q10 treatment in serious heart failure.
    Munkholm H; Hansen HH; Rasmussen K
    Biofactors; 1999; 9(2-4):285-9. PubMed ID: 10416042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial preservation by therapy with coenzyme Q10 during heart surgery.
    Judy WV; Stogsdill WW; Folkers K
    Clin Investig; 1993; 71(8 Suppl):S155-61. PubMed ID: 8241702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic effects of coenzyme Q10 on dilated cardiomyopathy: assessment by 123I-BMIPP myocardial single photon emission computed tomography (SPECT): a multicenter trial in Osaka University Medical School Group].
    Nishimura T; Hori M
    Kaku Igaku; 1996 Jan; 33(1):27-32. PubMed ID: 8819712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure.
    Rosenfeldt F; Hilton D; Pepe S; Krum H
    Biofactors; 2003; 18(1-4):91-100. PubMed ID: 14695924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated diastolic dysfunction of the myocardium and its response to CoQ10 treatment.
    Langsjoen PH; Langsjoen PH; Folkers K
    Clin Investig; 1993; 71(8 Suppl):S140-4. PubMed ID: 8241699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.